It is anticipated that further studies of genes (for example, MSN and ZRANB1) and clinically relevant SNPs (for example, rs2285218 in KIAA0040) will produce interesting novel mechanistic insights into GBM progression and oncogenesis. This evidence concerns the gene ZRANB1 and glioblastoma.